Revenue (GAAP) grew 13% year over year in the second quarter of 2025 but missed analyst expectations by $4.5 million (GAAP). Adjusted EBITDA dropped 21.8% compared to the same period in 2024, ...

R&D expense was $11.7 million for the three months ended June 30, 2025, compared to $7.6 million for the same period in 2024. The increase was primarily driven by higher research, development, ...